SEI Investments
TGTX icon

SEI Investments’s TG Therapeutics TGTX Stock Holding History

SEI Investments’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.7M Buy
340,588
+163,886
+93% +$6.71M 0.02% 840
2026
Q1 		$5.87M Buy
176,702
+103,634
+142% +$3.09M 0.01% 1444
2025
Q4 		$2.18M Buy
73,068
+33,801
+86% +$1.1M ﹤0.01% 1812
2025
Q3 		$1.42M Sell
39,267
-8,325
-17% -$274K ﹤0.01% 1829
2025
Q2 		$1.71M Buy
47,592
+15,740
+49% +$586K ﹤0.01% 1713
2025
Q1 		$1.26M Buy
31,852
+1,883
+6% +$63.4K ﹤0.01% 1815
2024
Q4 		$902K Sell
29,969
-61,471
-67% -$1.76M ﹤0.01% 1986
2024
Q3 		$2.14M Buy
91,440
+53,883
+143% +$1.18M ﹤0.01% 1657
2024
Q2 		$668K Sell
37,557
-1,283
-3% -$20.5K ﹤0.01% 2059
2024
Q1 		$591K Buy
+38,840
New +$619K ﹤0.01% 2059
2023
Q3 		– Sell
-222,097
Closed -$5.52M – 2695
2023
Q2 		$5.52M Buy
222,097
+164,243
+284% +$4.24M 0.01% 1150
2023
Q1 		$870K Buy
+57,854
New +$879K ﹤0.01% 1922
2022
Q1 		– Sell
-28,612
Closed -$544K – 2650
2021
Q4 		$544K Buy
28,612
+18,961
+196% +$492K ﹤0.01% 2066
2021
Q3 		$321K Sell
9,651
-15,820
-62% -$489K ﹤0.01% 2288
2021
Q2 		$988K Sell
25,471
-21,122
-45% -$829K ﹤0.01% 1823
2021
Q1 		$2.32M Buy
46,593
+15,460
+50% +$743K 0.01% 1387
2020
Q4 		$1.62M Buy
31,133
+8,407
+37% +$284K ﹤0.01% 1486
2020
Q3 		$608K Sell
22,726
-3,532
-13% -$81.3K ﹤0.01% 1821
2020
Q2 		$512K Buy
+26,258
New +$423K ﹤0.01% 1834
2018
Q3 		– Sell
-66
Closed -$1K – 3369
2018
Q2 		$1K Buy
66
+22
+50% +$303 ﹤0.01% 3523
2018
Q1 		$1K Hold
44
– – ﹤0.01% 3366
2017
Q4 		$0 Hold
44
– – ﹤0.01% 3487
2017
Q3 		$1K Buy
+44
New +$501 ﹤0.01% 3120

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

SEI Investments's TGTX Position: Q2 2026 in Review

SEI Investments increased its TG Therapeutics (TGTX) stake by 93% in Q2 2026, buying an estimated $6.71M and bringing the position to 340,588 shares worth $18.7M. The position accounts for 0.02% of the portfolio, ranked #840.

SEI Investments first reported a position in TGTX in Q3 2017 and has held it in 23 quarters since. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • SEI Investments held 340,588 shares of TG Therapeutics worth $18.7M as of Q2 2026.
  • SEI Investments bought 163,886 TG Therapeutics shares in Q2 2026, an estimated $6.71M.
  • TG Therapeutics made up 0.02% of SEI Investments's portfolio in Q2 2026, its #840 holding.
  • SEI Investments first reported a position in TG Therapeutics in Q3 2017 and has held it in 23 quarters since.
  • 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.